查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596211

可吸收血管支架市场：按材料类型、应用和最终用户划分 - 全球预测 2025-2030

Resorbable Vascular Scaffold Market by Material Type (Metal Based BVS, Polymer Based BVS), Application (Coronary Artery Stents, Peripheral Artery Stents), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年可吸收血管支架市值为5.0712亿美元，预计2024年将达到5.7657亿美元，复合年增长率为13.78%，到2030年将达到12.5252亿美元。

可吸收血管支架 (RVS) 是创新的生物可吸收支架，主要用于心臟介入治疗，透过为血管提供临时支撑来治疗冠状动脉疾病。这种需求源于其减少与传统金属支架相关的併发症的潜力，例如晚期支架血栓症，同时允许动脉在支架溶解后恢復自然运动和功能。在应用方面，RVS 在血管成形术中至关重要，其最终用途主要包括医院、心臟中心和门诊手术中心。 RVS 市场的推动因素包括心血管疾病的日益普及、生物分解性材料的进步以及对微创手术的日益偏好。然而，与金属支架相比，重大挑战可能会抑製成长，包括高成本、严格的监管要求以及有限的长期临床资料。新兴市场存在机会，医疗基础设施正在迅速改善，先进的医疗技术正在获得认可。与医学研究机构的策略联盟有可能促进创新，特别是在提高 RVS 的功效和安全性方面。公司应专注于开发具有缩短降解时间和改善机械性能的支架，以满足不同患者的需求。创新还可以透过製造适合个人解剖和疾病特异性的支架来实现个人化。鼓励市场相关人员投资全面的临床试验，以证实长期的安全性和有效性主张，并满足监管机构和医疗保健提供者的要求。总体而言，RVS 市场由于其在心臟护理领域的转型潜力而前景广阔，但要克服当前的限制并利用新兴的机会，需要在监管环境、成本管理和技术增强方面予以认真关注。

主要市场统计
基准年[2023] 5.0712 亿美元
预测年份 [2024] 57657万美元
预测年份 [2030] 12,525.2 亿美元
复合年增长率（%） 13.78%

市场动态：揭示快速发展的可吸收血管支架市场的关键市场洞察

可吸收血管支架市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 老化人口中 CAD 和 PAD 的风险增加
    • 临床试验数量和开发平臺
    • 心血管疾病盛行率增加
  • 市场限制因素
    • 存在替代方案
  • 市场机会
    • 增加外科研究和开发的资金
    • 倾向于血管成形术中的药物释放型装置
  • 市场挑战
    • 产品召回

波特的五力：驾驭可吸收血管支架市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解可吸收血管支架市场的外部影响

外部宏观环境因素在塑造可吸收血管支架市场的性能动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解可吸收血管支架市场的竞争格局

可吸收血管支架市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵可吸收血管支架市场供应商的绩效评估

FPNV定位矩阵是评估可吸收血管支架市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划可吸收血管支架市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，可吸收血管支架市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年族群中 CAD 和 PAD 的风险增加
      • 正在进行的临床试验和开发数量
      • 心血管疾病盛行率增加
    • 抑制因素
      • 存在替代方案
    • 机会
      • 增加外科研究和开发的资金
      • 血管成形术中药物释放型装置的趋势
    • 任务
      • 产品召回
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依材质类型分類的可吸收血管支架市场

  • 金属基BVS
  • 聚合物基 BVS

第七章可吸收血管支架市场：依应用分类

  • 冠状动脉支架
  • 週边动脉支架

第八章可吸收血管支架市场：依最终用户分类

  • 门诊手术中心
  • 心臟中心
  • 医院

第九章北美和南美可吸收血管支架市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太可吸收血管支架市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲可吸收血管支架市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • B. Braun Medical Inc.
  • Biotronik SE & Co. KG
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Limited
  • Reva Medical, Inc.
  • Terumo Corporation
  • Translumina
  • Wego Healthcare（Shenzhen）Co., Ltd.
Product Code: MRR-035AB9C0DAAB

The Resorbable Vascular Scaffold Market was valued at USD 507.12 million in 2023, expected to reach USD 576.57 million in 2024, and is projected to grow at a CAGR of 13.78%, to USD 1,252.52 million by 2030.

Resorbable vascular scaffolds (RVS) are innovative bioresorbable stents used primarily in cardiac interventions to treat coronary artery disease by providing temporary support to the blood vessel. The necessity arises from their potential to reduce complications associated with traditional metal stents, such as late stent thrombosis, while allowing the artery to restore its natural movement and function once the scaffold dissolves. In terms of application, RVS are pivotal in angioplasty procedures, and their end-use scope primarily spans across hospitals, cardiac centers, and ambulatory surgical centers. The market for RVS is driven by the increasing prevalence of cardiovascular disorders, advancements in biodegradable materials, and a growing preference for minimally invasive procedures. However, significant challenges, including high costs, stringent regulatory requirements, and limited long-term clinical data compared to metallic stents, could inhibit growth. Opportunities lie in emerging markets where healthcare infrastructure is rapidly improving, and there's an increasing acceptance of advanced medical technologies. Strategic collaborations with medical research institutions could expedite innovation, particularly in enhancing the efficacy and safety profiles of RVS. Companies should focus on developing scaffolds with improved degradation timelines and enhanced mechanical properties to meet diverse patient needs. Innovation can also be steered towards personalization, producing scaffolds that cater to individual anatomical peculiarities and disease specifics. Market players are advised to invest in comprehensive clinical trials to substantiate long-term safety and effectiveness claims, thereby satisfying both regulatory bodies and healthcare providers. Overall, the RVS market is promising due to its transformative potential in cardiac care; however, it demands meticulous effort in navigation through regulatory landscapes, cost management, and technological enhancements to surmount current limitations and capitalize on burgeoning opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 507.12 million
Estimated Year [2024] USD 576.57 million
Forecast Year [2030] USD 1,252.52 million
CAGR (%) 13.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Resorbable Vascular Scaffold Market

The Resorbable Vascular Scaffold Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Risk of CAD and PAD in the geriatric population
    • Number of clinical trials and development in pipeline
    • Increasing prevalence of cardiovascular diseases
  • Market Restraints
    • Presence of alternative methods
  • Market Opportunities
    • Growing funding for R&D of surgical procedures
    • Inclination towards drug-eluting devices for angioplasty
  • Market Challenges
    • Product recall

Porter's Five Forces: A Strategic Tool for Navigating the Resorbable Vascular Scaffold Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Resorbable Vascular Scaffold Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Resorbable Vascular Scaffold Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Resorbable Vascular Scaffold Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Resorbable Vascular Scaffold Market

A detailed market share analysis in the Resorbable Vascular Scaffold Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Resorbable Vascular Scaffold Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Resorbable Vascular Scaffold Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Resorbable Vascular Scaffold Market

A strategic analysis of the Resorbable Vascular Scaffold Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Resorbable Vascular Scaffold Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Medical Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Reva Medical, Inc., Terumo Corporation, Translumina, and Wego Healthcare (Shenzhen) Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Resorbable Vascular Scaffold Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material Type, market is studied across Metal Based BVS and Polymer Based BVS.
  • Based on Application, market is studied across Coronary Artery Stents and Peripheral Artery Stents.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Risk of CAD and PAD in the geriatric population
      • 5.1.1.2. Number of clinical trials and development in pipeline
      • 5.1.1.3. Increasing prevalence of cardiovascular diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of alternative methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing funding for R&D of surgical procedures
      • 5.1.3.2. Inclination towards drug-eluting devices for angioplasty
    • 5.1.4. Challenges
      • 5.1.4.1. Product recall
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Resorbable Vascular Scaffold Market, by Material Type

  • 6.1. Introduction
  • 6.2. Metal Based BVS
  • 6.3. Polymer Based BVS

7. Resorbable Vascular Scaffold Market, by Application

  • 7.1. Introduction
  • 7.2. Coronary Artery Stents
  • 7.3. Peripheral Artery Stents

8. Resorbable Vascular Scaffold Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Cardiac Centers
  • 8.4. Hospitals

9. Americas Resorbable Vascular Scaffold Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Resorbable Vascular Scaffold Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Resorbable Vascular Scaffold Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun Medical Inc.
  • 3. Biotronik SE & Co. KG
  • 4. Cardionovum GmbH
  • 5. Elixir Medical Corporation
  • 6. Kyoto Medical Planning Co., Ltd.
  • 7. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 8. Medtronic PLC
  • 9. Meril Life Sciences Pvt. Ltd.
  • 10. MicroPort Scientific Corporation
  • 11. OrbusNeich Medical Company Limited
  • 12. Reva Medical, Inc.
  • 13. Terumo Corporation
  • 14. Translumina
  • 15. Wego Healthcare (Shenzhen) Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. RESORBABLE VASCULAR SCAFFOLD MARKET RESEARCH PROCESS
  • FIGURE 2. RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. RESORBABLE VASCULAR SCAFFOLD MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESORBABLE VASCULAR SCAFFOLD MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RESORBABLE VASCULAR SCAFFOLD MARKET DYNAMICS
  • TABLE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. RESORBABLE VASCULAR SCAFFOLD MARKET, FPNV POSITIONING MATRIX, 2023